AstraZeneca secures US Breakthrough status for Enhertu in early breast cancer
Curasight reports first patient dosed in Phase 1 uTREAT trial in brain cancer
BioNTech completes acquisition of CureVac
BiBBInstruments reports additional US orders during targeted EndoDrill GI launch
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL
Genmab completes tender offer for Merus and opens subsequent offering period
NanOlogy launches drug development program for diffuse intrinsic pontine glioma treatment
Privo Technologies doses first patient in first-in-human clinical trial of PRV131
Senhwa Biosciences signs clinical supply agreement with BeOne Medicines
D3 Bio completes USD108m Series B financing round
Champions Oncology expands bioanalytical services with new technology and leadership
Poolbeg Pharma trial to feature in major CRS research programme